GHK-Cu peptide claims on TikTok: what the science says

What's this video probably claiming?

Based on the caption and hashtags, @justagrownwoman is almost certainly walking viewers through GHK-Cu (copper tripeptide-1) as a discovery worth sharing, framed as relevant to both sexes. The typical TikTok script for this peptide goes something like: it reverses skin aging, regrows hair, heals tissue, resets gene expression, and maybe even extends lifespan. The "did you know?" framing suggests a reveal-style hook, probably positioning GHK-Cu as an under-the-radar compound that doctors aren't talking about. That framing is common in peptide content and it's worth interrogating. GHK-Cu is a naturally occurring tripeptide found in human plasma, saliva, and urine. Plasma concentrations drop from roughly 200 ng/mL at age 20 to around 80 ng/mL by age 60, which is a real finding. Whether supplementing with exogenous GHK-Cu meaningfully reverses that decline in a clinical setting is a different question entirely.

What does the science actually show?

The most cited GHK-Cu researcher is Loren Pickart, whose decades of work established the peptide's role in wound healing and skin remodeling. A 2015 review by Pickart and Margolina in the journal Biomolecules summarized evidence that GHK-Cu modulates over 4,000 human genes in cell culture, promoting antioxidant and anti-inflammatory pathways. That sounds extraordinary, and cell culture studies do show real effects on collagen synthesis, metalloproteinase activity, and fibroblast proliferation. The problem is the jump from petri dish to human skin. Topical studies are more promising: a randomized controlled trial by Leyden et al. (2018, Journal of Cosmetic Dermatology) found that a GHK-Cu-containing cream improved skin laxity and reduced fine lines versus placebo over 12 weeks. Hair growth data is thinner. Animal studies suggest activation of hair follicle stem cells, but peer-reviewed human RCTs on GHK-Cu specifically for androgenetic alopecia are essentially absent as of 2024. Injectable GHK-Cu is a different product class entirely, and clinical data there is close to nonexistent in the published literature.

Where does the social media noise diverge from clinical reality?

Here is where TikTok peptide content usually goes sideways. The gene-expression data from Pickart's work gets weaponized to imply that GHK-Cu "reprograms" aging at a systemic level. That is a significant overreach from what in vitro transcriptomics can actually tell us. A cell that responds differently to a peptide in a dish does not confirm a clinical outcome in a living human. Bioavailability is also a real issue that creators almost never address. Oral GHK-Cu is likely degraded before meaningful absorption. Topical absorption through intact skin is partial at best. Injectable peptides bypass these barriers but introduce regulatory and safety questions that require medical supervision. The "for men or women" framing suggests this video may be positioning GHK-Cu as a universal anti-aging solution, which outruns the evidence. No regulatory body has approved GHK-Cu as a treatment for any condition. If the video implies it cures skin disease, hair loss, or systemic aging, that claim should be rejected as unsupported by current clinical data.

What should you actually know?

GHK-Cu is genuinely interesting science. It is not snake oil, but it is also not a proven clinical therapy for most of what TikTok attributes to it. Topical formulations have the most human evidence and the best safety profile. The 2018 Leyden data and earlier split-face studies suggest real but modest cosmetic benefits. Hair regrowth claims are speculative without controlled human trials. Systemic anti-aging effects from injectable GHK-Cu remain unproven in peer-reviewed human studies. Anyone considering injectable peptide therapy should be working with a licensed clinician who can order appropriate labs, monitor outcomes, and account for individual health history. The fact that GHK-Cu is a naturally occurring human peptide does not mean exogenous dosing is automatically safe or effective at scale. Compounded injectable versions are not equivalent to any approved pharmaceutical product. Approach the "did you know" framing with appropriate skepticism: what you probably did not know is how thin the human clinical trial base actually is.